HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Large mass affecting retroperitoneal great vessels: a rare presentation of a cancer of unknown primary with diagnostic dilemma and challenged surgical intervention.

AbstractINTRODUCTION:
Cancers of unknown primary site (CUPs) consist of a clinical entity which accounts for 3-5% of all solid tumor patients. They are metastatic solid tumors whose fundamental characteristic is the absence of identifiable site of the primary tumor.
CASE REPORT:
We report the case of a completely asymptomatic 34-year-old man with a palpated huge mass found incidentally in the left abdomen. All the investigations were normal. During the operation, a large mass was identified 2 cm below the left renal artery which was displacing and encompassing the great retroperitoneal vessels and the left ureter. A complete resection of the mass was performed while the histological examination revealed a solitary retroperitoneal lymph node categorized as metastatic adenocarcinoma of unknown primary site.
CONCLUSION:
It is essential to assess the high incidence of patients with cancer who present with CUP. Early surgical excision of the metastatic lesion followed by adjuvant combination chemotherapy should be considered for patients with only a single site of malignancy.
AuthorsParaskevi Stakia, Panagiotis Lagos, Stavros Gourgiotis, Vasilios D Tzilalis, Stavros Aloizos, Nikolaos S Salemis
JournalJournal of gastrointestinal cancer (J Gastrointest Cancer) Vol. 40 Issue 1-2 Pg. 55-8 ( 2009) ISSN: 1941-6636 [Electronic] United States
PMID19513858 (Publication Type: Case Reports, Journal Article)
Topics
  • Adenocarcinoma (secondary, therapy)
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Blood Vessels (pathology)
  • Combined Modality Therapy
  • Humans
  • Incidental Findings
  • Lymphatic Metastasis (pathology)
  • Male
  • Neoplasms, Unknown Primary (pathology, therapy)
  • Retroperitoneal Neoplasms (secondary, therapy)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: